SEC Comment Letter 0000000000-25-000490 to Cellectis S.A. (CLLS)

Cellectis S.A.
Date: Jan. 16, 2025 · CIK: 0001627281 · Accession: 0000000000-25-000490

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-284302

Date

January 16, 2025

Author

André Choulika

Form

UPLOAD

Company

Cellectis S.A.

Letter

January 16, 2025 André Choulika Chief Executive Officer Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France Re:Cellectis S.A. Registration Statement on Form F-3 Filed January 15, 2025 File No. 333-284302 Dear André Choulika: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Peter E. Devlin

Show Raw Text

January 16, 2025
André Choulika
Chief Executive Officer
Cellectis S.A.
8, rue de la Croix Jarry
75013 Paris, France
Re:Cellectis S.A.
Registration Statement on Form F-3
Filed January 15, 2025
File No. 333-284302
Dear André Choulika:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Peter E. Devlin

SecProbe.io